First-Ever FDA Approval for Upper-Track Bladder Ca Tx
]]>(MedPage Today) -- WASHINGTON--The FDA granted a first-ever approval of a treatment for an uncommon form of bladder cancer--mitomycin gel (Jelmyto) for low-grade upper track urothelial cancer (UTUC).UTUC affects 6,000-8,000 people a year...
Read more »